HUB Investment Partners LLC Has $12.45 Million Stock Holdings in Johnson & Johnson $JNJ - MarketBeat

Legacy Capital Group California Inc. Has $1.56 Million Stake in Johnson & Johnson $JNJ - MarketBeat

Guardian Capital LP Has $27.44 Million Holdings in Johnson & Johnson $JNJ - MarketBeat

Blair William & Co. IL Has $175.83 Million Stake in Johnson & Johnson $JNJ - MarketBeat

BofA Boosts Johnson & Johnson (JNJ) Price Target as Pipeline Outlook Improves - Insider Monkey

Jobs Crash, War Flares: Smart Money Hides In These Stocks

Johnson & Johnson (JNJ) Settles Antitrust Suit for $65 Million - GuruFocus

FDA Clears Johnson & Johnson's Multiple Myeloma Combo Drug After Strong Survival Results

Dividend Aristocrats in a Shaky Market: KO, PG, JNJ, and 2 Others Built to Last - AOL.com

Dividend Aristocrats in a Shaky Market: KO, PG, JNJ, and 2 Others Built to Last - Yahoo Finance

Dividend Aristocrats in a Shaky Market: KO, PG, JNJ, and 2 Others Built to Last - 24/7 Wall St.

Integrity Advisory Solutions LLC Buys New Shares in Johnson & Johnson $JNJ - MarketBeat

Pitcairn Co. Trims Stock Holdings in Johnson & Johnson $JNJ - MarketBeat

Quantbot Technologies LP Sells 35,348 Shares of Johnson & Johnson $JNJ - MarketBeat

Edgar Lomax Co. VA Reduces Stake in Johnson & Johnson $JNJ - MarketBeat

Johnson & Johnson $JNJ Shares Sold by Berry Wealth Group LP - MarketBeat

Johnson & Johnson (NYSE:JNJ) Shares Down 2.3% - What's Next? - MarketBeat

Johnson & Johnson (JNJ) Declines More Than Market: Some Information for Investors - Yahoo Finance

JNJ: JP Morgan Maintains Neutral Rating, Raises Price Target to $250 | JNJ Stock News - GuruFocus

Johnson & Johnson (JNJ) Gains FDA Approval for New Multiple Myel - GuruFocus

Johnson & Johnson (NYSE:JNJ) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says - MarketBeat

Johnson & Johnson (JNJ) Gets FDA Nod for Tec-Dara in Multiple My - GuruFocus

Johnson & Johnson Stock (JNJ) Moved Down by 3.29% on Mar 5: Drivers Behind the Movement - TradingKey

JT Stratford LLC Purchases 4,216 Shares of Johnson & Johnson $JNJ - MarketBeat

Johnson & Johnson $JNJ Stock Holdings Lowered by Burgundy Asset Management Ltd. - MarketBeat

Cytokines Market Global Forecast 2026-2032: Precise Treatments, Strategic Partnerships, and Supply Chain Resilience Fueling the $95+ Billion Market

Should FDA Fast Track Status for Nipocalimab in Lupus Reshape Johnson & Johnson’s (JNJ) Immunology Ambitions? - simplywall.st

Smith Chas P & Associates PA Cpas Sells 100,283 Shares of Johnson & Johnson $JNJ - MarketBeat

Johnson & Johnson (JNJ) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance

Johnson & Johnson $JNJ Holdings Decreased by Mcdonald Partners LLC - MarketBeat

10 Stocks to Own as Middle East Tensions Drive Investors Toward Safety

Cresset Asset Management LLC Purchases 4,805 Shares of Johnson & Johnson $JNJ - MarketBeat

CI Investments Inc. Decreases Stock Holdings in Johnson & Johnson $JNJ - MarketBeat

AustralianSuper Pty Ltd Acquires 77,000 Shares of Johnson & Johnson $JNJ - MarketBeat

JNJ Earnings History & Surprises | EPS & Revenue Results | JOHNSON & JOHNSON (NYSE:JNJ) - ChartMill

5 Top Dividend Stocks for March 2026: Chevron (CVX) and Johnson & Johnson (JNJ) Lead the Pack - Blockonomi

Johnson & Johnson (JNJ) Valuation Check As New Prostate Cancer Therapy Data Progresses - simplywall.st

Johnson & Johnson $JNJ Shares Acquired by Victory Capital Management Inc. - MarketBeat

Johnson & Johnson $JNJ Shares Sold by State Farm Mutual Automobile Insurance Co. - MarketBeat

South Dakota Investment Council Trims Stock Position in Johnson & Johnson $JNJ - MarketBeat

Focus Partners Advisor Solutions LLC Raises Position in Johnson & Johnson $JNJ - MarketBeat

Johnson & Johnson (NYSE:JNJ) Reaches New 52-Week High - Still a Buy? - MarketBeat

Blueprint Investment Partners LLC Takes Position in Johnson & Johnson $JNJ - MarketBeat

Johnson & Johnson (NYSE:JNJ) Moves Higher As Dow Jones Stocks Regain Traction - Kalkine Media

Johnson & Johnson (JNJ) PT Raised to $253 at BofA Securities - StreetInsider

JNJ Stock Today: 52-Week High Test on $20B DePuy Sale Talk – March 02 - Meyka

AbbVie Says 55% Of Crohn's Patients Reached Remission With Skyrizi, Bolsters Competitive Positioning Against Johnson & Johnson

Johnson & Johnson $JNJ Shares Bought by Kingsview Wealth Management LLC - MarketBeat

Elo Mutual Pension Insurance Co Purchases 21,128 Shares of Johnson & Johnson $JNJ - MarketBeat

Fisher Asset Management LLC Buys 173,936 Shares of Johnson & Johnson $JNJ - MarketBeat

Journey Strategic Wealth LLC Decreases Stock Holdings in Johnson & Johnson $JNJ - MarketBeat

Johnson & Johnson $JNJ Shares Sold by Laurel Wealth Advisors LLC - MarketBeat

Antibiotics Market - 4.07% CAGR Forecast for 2026-2031 as Antimicrobial Innovation Strengthens Demand, Says Mordor Intelligence

Okabena Investment Services Inc. Acquires 7,249 Shares of Johnson & Johnson $JNJ - MarketBeat